Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

A critical role of autophagy in antileukemia/lymphoma effects of APO866, an inhibitor of NAD biosynthesis.

Ginet V, Puyal J, Rummel C, Aubry D, Breton C, Cloux AJ, Majjigapu SR, Sordat B, Vogel P, Bruzzone S, Nencioni A, Duchosal MA, Nahimana A.

Autophagy. 2014 Apr;10(4):603-17. doi: 10.4161/auto.27722. Epub 2014 Jan 17.

2.

The anti-lymphoma activity of APO866, an inhibitor of nicotinamide adenine dinucleotide biosynthesis, is potentialized when used in combination with anti-CD20 antibody.

Nahimana A, Aubry D, Breton CS, Majjigapu SR, Sordat B, Vogel P, Duchosal MA.

Leuk Lymphoma. 2014 Sep;55(9):2141-50. doi: 10.3109/10428194.2013.869325. Epub 2014 Jan 24.

PMID:
24283753
3.

Anti-cancer activity of 5-O-alkyl 1,4-imino-1,4-dideoxyribitols.

Bello C, Dal Bello G, Cea M, Nahimana A, Aubry D, Garuti A, Motta G, Moran E, Fruscione F, Pronzato P, Grossi F, Patrone F, Ballestrero A, Dupuis M, Sordat B, Zimmermann K, Loretan J, Wartmann M, Duchosal MA, Nencioni A, Vogel P.

Bioorg Med Chem. 2011 Dec 15;19(24):7720-7. doi: 10.1016/j.bmc.2011.07.053. Epub 2011 Jul 30.

PMID:
22079865
4.

The plasminogen system in microdissected colonic mucosa distant from an isolated adenoma.

Saucy F, Bachmann D, Peterman O, Sordat B, Sordat I, Dorta G.

Pathol Oncol Res. 2011 Mar;17(1):25-31. doi: 10.1007/s12253-010-9268-4. Epub 2010 May 23.

PMID:
20496126
5.

Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.

Bello C, Cea M, Dal Bello G, Garuti A, Rocco I, Cirmena G, Moran E, Nahimana A, Duchosal MA, Fruscione F, Pronzato P, Grossi F, Patrone F, Ballestrero A, Dupuis M, Sordat B, Nencioni A, Vogel P.

Bioorg Med Chem. 2010 May 1;18(9):3320-34. doi: 10.1016/j.bmc.2010.03.009. Epub 2010 Mar 9.

PMID:
20346684
6.

Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE.

Bruzzone S, Fruscione F, Morando S, Ferrando T, Poggi A, Garuti A, D'Urso A, Selmo M, Benvenuto F, Cea M, Zoppoli G, Moran E, Soncini D, Ballestrero A, Sordat B, Patrone F, Mostoslavsky R, Uccelli A, Nencioni A.

PLoS One. 2009 Nov 19;4(11):e7897. doi: 10.1371/journal.pone.0007897.

7.

The combination of chemotherapy and intraperitoneal MegaFas Ligand improves treatment of ovarian carcinoma.

Etter AL, Bassi I, Germain S, Delaloye JF, Tschopp J, Sordat B, Dupuis M.

Gynecol Oncol. 2007 Oct;107(1):14-21. Epub 2007 Jun 29.

PMID:
17604087
8.

Profiling of the tetraspanin web of human colon cancer cells.

Le Naour F, André M, Greco C, Billard M, Sordat B, Emile JF, Lanza F, Boucheix C, Rubinstein E.

Mol Cell Proteomics. 2006 May;5(5):845-57. Epub 2006 Feb 7.

9.

A Fas agonist induces high levels of apoptosis in haematological malignancies.

Greaney P, Nahimana A, Lagopoulos L, Etter AL, Aubry D, Attinger A, Beltraminelli N, Huni B, Bassi I, Sordat B, Demotz S, Dupuis M, Duchosal MA.

Leuk Res. 2006 Apr;30(4):415-26. Epub 2005 Sep 21.

PMID:
16181674
10.

Tumor galectinology: insights into the complex network of a family of endogenous lectins.

Lahm H, André S, Hoeflich A, Kaltner H, Siebert HC, Sordat B, von der Lieth CW, Wolf E, Gabius HJ.

Glycoconj J. 2004;20(4):227-38. Review.

PMID:
15115907
11.

Molecular biological fingerprinting of human lectin expression by RT-PCR.

Lahm H, André S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ.

Methods Enzymol. 2003;362:287-97. No abstract available.

PMID:
12968371
12.

Complementary DNA arrays identify CD63 tetraspanin and alpha3 integrin chain as differentially expressed in low and high metastatic human colon carcinoma cells.

Sordat I, Decraene C, Silvestre T, Petermann O, Auffray C, Piétu G, Sordat B.

Lab Invest. 2002 Dec;82(12):1715-24.

PMID:
12480921
13.

Bombesin stimulates invasion and migration of Isreco1 colon carcinoma cells in a Rho-dependent manner.

Saurin JC, Fallavier M, Sordat B, Gevrey JC, Chayvialle JA, Abello J.

Cancer Res. 2002 Aug 15;62(16):4829-35.

14.

Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures.

Lahm H, André S, Hoeflich A, Fischer JR, Sordat B, Kaltner H, Wolf E, Gabius HJ.

J Cancer Res Clin Oncol. 2001;127(6):375-86.

PMID:
11414198
15.

Methylation silencing and mutations of the p14ARF and p16INK4a genes in colon cancer.

Burri N, Shaw P, Bouzourene H, Sordat I, Sordat B, Gillet M, Schorderet D, Bosman FT, Chaubert P.

Lab Invest. 2001 Feb;81(2):217-29.

PMID:
11232644
16.

Tumor cell budding and laminin-5 expression in colorectal carcinoma can be modulated by the tissue micro-environment.

Sordat I, Rousselle P, Chaubert P, Petermann O, Aberdam D, Bosman FT, Sordat B.

Int J Cancer. 2000 Dec 1;88(5):708-17. Erratum in: Int J Cancer 2001 Mar 15;91(6):900-1.

17.

Protein kinase C isoforms involved in regulation of cell shape and locomotion of human fibrosarcoma HT1080 cells.

Keller HU, Hunziker IP, Sordat B, Niggli V, Sroka J.

Int J Cancer. 2000 Oct 15;88(2):195-203.

19.

Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells.

Schneider MR, Hoeflich A, Fischer JR, Wolf E, Sordat B, Lahm H.

Cancer Lett. 2000 Apr 3;151(1):31-8.

PMID:
10766420
20.

LAT2, a new basolateral 4F2hc/CD98-associated amino acid transporter of kidney and intestine.

Rossier G, Meier C, Bauch C, Summa V, Sordat B, Verrey F, Kühn LC.

J Biol Chem. 1999 Dec 3;274(49):34948-54.

21.

Bombesin stimulates adhesion, spreading, lamellipodia formation, and proliferation in the human colon carcinoma Isreco1 cell line.

Saurin JC, Némoz-Gaillard E, Sordat B, Cuber JC, Coy DH, Abello J, Chayvialle JA.

Cancer Res. 1999 Feb 15;59(4):962-7.

22.

APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth.

Hahne M, Kataoka T, Schröter M, Hofmann K, Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE, Sordat B, Rimoldi D, Tschopp J.

J Exp Med. 1998 Sep 21;188(6):1185-90.

23.

Differential expression of laminin-5 subunits and integrin receptors in human colorectal neoplasia.

Sordat I, Bosman FT, Dorta G, Rousselle P, Aberdam D, Blum AL, Sordat B.

J Pathol. 1998 May;185(1):44-52.

PMID:
9713359
24.

The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor.

Spencer SD, Di Marco F, Hooley J, Pitts-Meek S, Bauer M, Ryan AM, Sordat B, Gibbs VC, Aguet M.

J Exp Med. 1998 Feb 16;187(4):571-8.

25.

Alterations in plasminogen activation correlate with epithelial cell dysplasia grading in colorectal adenomas.

Protiva P, Sordat I, Chaubert P, Saraga E, Trân-Thang C, Sordat B, Blum AL, Dorta G.

Br J Cancer. 1998;77(2):297-304.

26.
28.

Abnormal T lymphocyte development induced by targeted overexpression of IkappaB alpha.

Esslinger CW, Wilson A, Sordat B, Beermann F, Jongeneel CV.

J Immunol. 1997 Jun 1;158(11):5075-8.

PMID:
9164919
29.

Role of integrins and evidence for two distinct mechanisms mediating human colorectal carcinoma cell interaction with peritoneal mesothelial cells and extracellular matrix.

Schlaeppi M, Rüegg C, Trân-Thang C, Chapuis G, Tevaearai H, Lahm H, Sordat B.

Cell Adhes Commun. 1997 Mar;4(6):439-55.

PMID:
9177905
30.

Genetic heterogeneity in sporadic colorectal adenomas.

Saraga E, Bautista D, Dorta G, Chaubert P, Martin P, Sordat B, Protiva P, Blum A, Bosman F, Benhattar J.

J Pathol. 1997 Mar;181(3):281-6.

PMID:
9155713
32.

In situ stromal expression of the urokinase/plasmin system correlates with epithelial dysplasia in colorectal adenomas.

Sordat I, Chaubert P, Protiva P, Guillou L, Mazzucchelli L, Saraga E, Benhattar J, Trân-Thang C, Blum AL, Dorta G, Sordat B.

Am J Pathol. 1997 Jan;150(1):283-95.

33.

Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells.

Trân-Thang C, Kruithof E, Lahm H, Schuster WA, Tada M, Sordat B.

Br J Cancer. 1996 Sep;74(6):846-52.

34.

Detection of rare circulating human colon tumor cells in a nude mouse xenograft model.

Pages JC, Sordat B, Bautista D, Costa J, Benhattar J.

Cancer Lett. 1996 Aug 23;106(1):139-44.

PMID:
8827058
35.

Human colon carcinoma cells synthesize and secrete alpha 1-proteinase inhibitor.

Keppler D, Markert M, Carnal B, Berdoz J, Bamat J, Sordat B.

Biol Chem Hoppe Seyler. 1996 May;377(5):301-11.

PMID:
8828821
36.

Differential effect of interleukin-4 and transforming growth factor beta 1 on expression of proto-oncogenes and autocrine insulin-like growth factor II in colorectal carcinoma cells.

Lahm H, Amstad P, Yilmaz A, Fischer JR, Givel JC, Odartchenko N, Sordat B.

Biochem Biophys Res Commun. 1996 Mar 18;220(2):334-40.

PMID:
8645306
37.

Expression of the alpha 6, beta 1 and beta 4 integrin subunits, basement membrane organization and proteolytic capacities in low and high metastatic human colon carcinoma xenografts.

Daémi N, Vallet T, Thomasset N, Jacquier MF, Zebda N, Doré JF, Sordat B, Rémy L.

Invasion Metastasis. 1995;15(3-4):103-15.

PMID:
8621266
38.

Human Co115 colon carcinoma cells potentiate the degradation of laminin mediated by tissue-type plasminogen activator.

Tran-Thang C, Vouillamoz D, Kruithof EK, Sordat B.

J Cell Physiol. 1994 Nov;161(2):285-92.

PMID:
7962113
39.

Latency of cathepsin B secreted by human colon carcinoma cells is not linked to secretion of cystatin C and is relieved by neutrophil elastase.

Keppler D, Waridel P, Abrahamson M, Bachmann D, Berdoz J, Sordat B.

Biochim Biophys Acta. 1994 May 25;1226(2):117-25.

PMID:
8204657
40.

Secretion of cathepsin B and tumour invasion.

Keppler D, Abrahamson M, Sordat B.

Biochem Soc Trans. 1994 Feb;22(1):43-9. Review. No abstract available.

PMID:
8206267
41.

Laminin degradation by human colon carcinoma cells: a role for urinary and tissue plasminogen activators.

Sordat BC, Tran-Thang C.

Invasion Metastasis. 1994-1995;14(1-6):223-33.

PMID:
7657515
42.

Malignant progression of SV40-immortalised human milk epithelial cells.

Yilmaz A, Gaide AC, Sordat B, Borbenyi Z, Lahm H, Imam A, Schreyer M, Odartchenko N.

Br J Cancer. 1993 Nov;68(5):868-73.

43.

The role of the urokinase receptor in extracellular matrix degradation by HT29 human colon carcinoma cells.

Reiter LS, Kruithof EK, Cajot JF, Sordat B.

Int J Cancer. 1993 Feb 1;53(3):444-50.

PMID:
8381394
44.

Cystatin C and cathepsin B in human colon carcinoma: expression by cell lines and matrix degradation.

Corticchiato O, Cajot JF, Abrahamson M, Chan SJ, Keppler D, Sordat B.

Int J Cancer. 1992 Oct 21;52(4):645-52.

PMID:
1399147
45.

Responsiveness of three newly established human colorectal cancer cell lines to transforming growth factors beta 1 and beta 2.

Suardet L, Gaide AC, Calmès JM, Sordat B, Givel JC, Eliason JF, Odartchenko N.

Cancer Res. 1992 Jul 1;52(13):3705-12.

46.

Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line.

Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J.

Proc Natl Acad Sci U S A. 1992 May 15;89(10):4495-9.

47.

Invasion and metastasis, a recurring theme in multiple fields.

Sordat B.

Invasion Metastasis. 1991;11(2):65. No abstract available.

PMID:
1917386
48.
49.

Plasminogen-activator inhibitor type 1 is a potent natural inhibitor of extracellular matrix degradation by fibrosarcoma and colon carcinoma cells.

Cajot JF, Bamat J, Bergonzelli GE, Kruithof EK, Medcalf RL, Testuz J, Sordat B.

Proc Natl Acad Sci U S A. 1990 Sep;87(18):6939-43.

50.

Supplemental Content

Loading ...
Support Center